Fibrosis–a common pathway to organ injury and failure
The DOI matches its Crossref record; 117 of the 118 references it cites were found in a registry or an index.
Abstract
Fibrosis is a consequence of the inflammatory response. When fibrotic tissue becomes excessive, it can have diverse pathophysiological effects on a number of organ systems. The mechanisms underlying fibrosis and approaches to therapy are reviewed.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatocyte injury, apoptosis and necrosis promote a sterile inflammatory response. This includes activation of KCs to clear necrotic debris, recruitment of lymphocytes and bone-marrow-derived monocytes, extracellular matrix (ECM) remodelling, myofibroblast activation, angiogenesis, and hepatocyte regeneration and differentiation to replace lost hepatocytes.11,31,32”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
In the citing paper
“Both receptors are independently involved in regulation of cell adhesion, differentiation, proliferation of myofibroblasts and migration of both myofibroblasts and macrophages.31”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [31]
Citations
Cites
Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis
Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654
A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
Sanyal, A. J., Chalasani, N., Kowdley, K. V., McCullough, A., Diehl, A. M., Bass, N. M., Neuschwander-Tetri, B. A., Lavine, J. E., Tonascia, J., Unalp, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907929 · Cited by 3,327
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,128
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Endothelial-to-mesenchymal transition contributes to cardiac fibrosis
Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., et al. (2007) · Nature Medicine · doi:10.1038/nm1613 · Cited by 2,222
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Hinz, B., Phan, S. H., Thannickal, V. J., Galli, A., Bochaton-Piallat, M.-L., & Gabbiani, G. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070112 · Cited by 2,068
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Research works printed but not linked: 1
- TORAFIC Investigators Group, 2011, Clin Ther, 33, 1204.e3
Cited by
Items 301–400 of 1,001
Zhang, C., Wang, L., Ali, T., Li, L., Bi, X., Wang, J., Lü, G., Shao, Y., Vuitton, D. A., Wen, H., et al. (2016) · Parasites & Vectors · doi:10.1186/s13071-016-1562-x · Cited by 56
Gregorio, J. D., Sferra, R., Speca, S., Vetuschi, A., Dubuquoy, C., Desreumaux, P., Pompili, S., Cristiano, L., Gaudio, E., Flati, V., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171093 · Cited by 61
RetractedThe host response in tissue engineering: Crosstalk between immune cells and cell-laden scaffolds
Saleh, L. S., & Bryant, S. J. (2018) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2018.03.006 · Cited by 54
Molecular Profiling Reveals a Common Metabolic Signature of Tissue Fibrosis
Zhang, J., Muise, E. S., Han, S., Kutchukian, P. S., Costet, P., Zhu, Y., Kan, Y., Zhou, H., Shah, V., Huang, Y., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100056 · Cited by 60
Okamura, D. M., Brewer, C. M., Wakenight, P., Bahrami, N. M., Bernardi, K. G., Tran, A., Olson, J., Shi, X., Yeh, S.-Y., Piliponsky, A. M., et al. (2021) · iScience · doi:10.1016/j.isci.2021.103269 · Cited by 54
Bernardo, B. C., Nguyen, S. S., Gao, X., Tham, Y. K., Ooi, J. Y. Y., Patterson, N. L., Kiriazis, H., Su, Y., Thomas, C. J., Lin, R. C. Y., et al. (2016) · Scientific Reports · doi:10.1038/srep22442 · Cited by 53
Identification of Common Genes and Pathways in Eight Fibrosis Diseases
Gu, C., Shi, X., Dang, X., Chen, J., Chen, C., Chen, Y., Pan, X., & Huang, T. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.627396 · Cited by 58
Metabolic Reprogramming and Renal Fibrosis
Zhu, X., Jiang, L., Long, M., Wei, X. S., Hou, Y., & Du, Y. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.746920 · Cited by 66
Hamanaka, R. B., & Mutlu, G. M. (2021) · Amino Acids · doi:10.1007/s00726-021-02996-8 · Cited by 54
He, S., Wang, Y., Liu, J., Li, P., Luo, X., & Zhang, B. (2023) · International Journal of Medical Sciences · doi:10.7150/ijms.77955 · Cited by 57
The current landscape of antifibrotic therapy across different organs: A systematic approach
Fuster‐Martínez, I., & Calatayud, S. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107245 · Cited by 64
Mitogen-Activated Protein Kinases and Hypoxic/Ischemic Nephropathy
Luo, F., Shi, J., Shi, Q., Xu, X., Xia, Y., & He, X. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000447812 · Cited by 54
Pitha, I., Oglesby, E., Chow, A. L., Kimball, E., Pease, M. E., Schaub, J. A., & Quigley, H. A. (2018) · Translational Vision Science & Technology · doi:10.1167/tvst.7.6.6 · Cited by 55
The role of extracellular vesicles in renal fibrosis
Jing, H., Tang, S., Lin, S., Liao, M., Chen, H., & Zhou, J. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1605-2 · Cited by 54
Pulivendala, G., Bale, S., & Godugu, C. (2020) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2020.114913 · Cited by 54
Grove, L. M., Mohan, M. L., Abraham, S., Scheraga, R. G., Southern, B. D., Crish, J. F., Naga Prasad, S. V., & Olman, M. A. (2019) · Science Signaling · doi:10.1126/scisignal.aau1533 · Cited by 51
Accelerated Vascular Aging as a Paradigm for Hypertensive Vascular Disease: Prevention and Therapy
Barton, M., Husmann, M. J. W., & Meyer, M. R. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.02.062 · Cited by 56
Aldehyde dehydrogenase inhibition blocks mucosal fibrosis in human and mouse ocular scarring
Ahadome, S. D., Abraham, D., Rayapureddi, S., Saw, V. P. J., Saban, D. R., Calder, V. L., Norman, J. T., Ponticos, M., Daniels, J. T., & Dart, J. K. G. (2016) · JCI Insight · doi:10.1172/jci.insight.87001 · Cited by 54
Gosset, C., Viglietti, D., Rabant, M., Verine, J., Aubert, O., Glotz, D., Legendre, C. M., Taupin, J., Huyen, J. D. V., Loupy, A., et al. (2017) · Kidney International · doi:10.1016/j.kint.2017.03.033 · Cited by 58
Inhibition of EP300 and DDR1 synergistically alleviates pulmonary fibrosis in vitro and in vivo
Jia, T., Zhang, M., Wen, Z., Wang, B., Zhang, L., Ou, Y., Tang, X., Yu, X., & Jiang, Q. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.132 · Cited by 57
Lin, H., Wang, T., Ruan, Y., Liu, K., Li, H., Wang, S., Li, M., & Liu, J. (2018) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2018.07.013 · Cited by 53
New Aspects of Kidney Fibrosis–From Mechanisms of Injury to Modulation of Disease
Moeller, M. J., Kramann, R., Lammers, T., Höppe, B., Latz, E., Ludwig‐Portugall, I., Boor, P., Floege, J., Kurts, C., Weiskirchen, R., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.814497 · Cited by 57
Novel inhalation therapy in pulmonary fibrosis: principles, applications and prospects
Zheng, M., Zhu, W., Gao, F., Zhuo, Y., Mo, Z., Wu, G., & Feng, C. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02407-6 · Cited by 56
miR-323a-3p regulates lung fibrosis by targeting multiple profibrotic pathways
Ge, L., Habiel, D. M., Hansbro, P. M., Kim, R., Gharib, S. A., Edelman, J. D., Königshoff, M., Parimon, T., Brauer, R., Huang, Y., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.90301 · Cited by 52
Notch Signaling in Ischemic Damage and Fibrosis: Evidence and Clues from the Heart
Nistri, S., Sassoli, C., & Bani, D. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00187 · Cited by 50
Suppression of Cavernosal Fibrosis in a Rat Model
Cho, M., Song, W. H., & Paick, J. (2018) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2018.02.007 · Cited by 51
Fibronectin has multifunctional roles in posterior capsular opacification (PCO)
Shihan, M. H., Kanwar, M., Wang, Y., Jackson, E., Faranda, A. P., & Duncan, M. K. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.02.004 · Cited by 60
Liu, Q., Zhang, Q., Wang, K., Wang, S., Lu, D., Li, Z., Geng, J., Ping, F., Wang, Y., & Shan, Q. (2015) · Scientific Reports · doi:10.1038/srep18582 · Cited by 49
Pulido, D., Sharma, U., Goff, S. V., Hussain, S., Cordes, S., Mariano, N., Bettler, E., Moali, C., Aghajari, N., Hohenester, E., et al. (2018) · Structure · doi:10.1016/j.str.2018.06.011 · Cited by 52
Sun, C., Tian, X., Jia, Y., Yang, M., Li, Y., & Fernig, D. G. (2022) · Open Biology · doi:10.1098/rsob.210356 · Cited by 53
Arthrofibrosis Nightmares: Prevention and Management Strategies
Lee, D. R., Therrien, E., Song, B. M., Camp, C. L., Krych, A. J., Stuart, M. J., Abdel, M. P., & Levy, B. A. (2022) · Sports Medicine and Arthroscopy Review · doi:10.1097/jsa.0000000000000324 · Cited by 57
Epigenetics as a versatile regulator of fibrosis
Liu, Y., Wen, D., Ho, C., Li, Y., Zheng, D., O’Reilly, S., Gao, Y., Li, Q., & Zhang, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04018-5 · Cited by 55
Critical Role of histone deacetylase 3 in the regulation of kidney inflammation and fibrosis
Wang, Y., Jiao, B., Hu, Z., & Wang, Y. (2024) · Kidney International · doi:10.1016/j.kint.2024.01.010 · Cited by 51
Ascorbic acid promotes a TGF β 1-induced myofibroblast phenotype switch
Piersma, B., Wouters, O. Y., de Rond, S., Boersema, M., Gjaltema, R. A. F., & Bank, R. A. (2017) · Physiological Reports · doi:10.14814/phy2.13324 · Cited by 58
Dekkers, I. A., & Lamb, H. J. (2018) · British Journal of Radiology · doi:10.1259/bjr.20170825 · Cited by 48
Lu, S., Strand, K. A., Mutryn, M. F., Tucker, R. M., Jolly, A., Furgeson, S. B., Moulton, K. S., Nemenoff, R. A., & Weiser‐Evans, M. C. M. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.313757 · Cited by 50
Ihara, K., SKUPIEN, J. K., Kobayashi, H. H., Dom, Z. I. M., Wilson, J. M., O’Neil, K. V., Badger, H. S., Bowsman, L. M., Satake, E., Breyer, M. D., et al. (2020) · Diabetes Care · doi:10.2337/dc20-0630 · Cited by 51
Yu, M., Wu, H., Wang, J., Chen, X., Pan, J., Liu, P., Zhang, J., Chen, Y., Zhu, W., Tang, C., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100531 · Cited by 52
Lagoutte, P., Bettler, E., Goff, S. V., & Moali, C. (2021) · Matrix Biology Plus · doi:10.1016/j.mbplus.2021.100062 · Cited by 58
Bobowski-Gerard, M., Boulet, C., Zummo, F. P., Dubois-Chevalier, J., Gheeraert, C., Bou Saleh, M., Strub, J.-M., Farce, A., Ploton, M., Guille, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-33063-9 · Cited by 51
AASLD Practice Guideline on noninvasive liver disease assessment of portal hypertension
Sterling, R. K., Asrani, S. K., Levine, D., Duarte‐Rojo, A., Patel, K., Fiel, M. I., Leung, D. H., Taouli, B. A., Alsawas, M., Murad, M. H., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000844 · Cited by 60
Self-citationHedgehog Signaling Demarcates a Niche of Fibrogenic Peribiliary Mesenchymal Cells
Gupta, V., Gupta, I., Park, J., Bram, Y., & Schwartz, R. E. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.03.075 · Cited by 53
MicroRNA-99b-3p promotes angiotensin II-induced cardiac fibrosis in mice by targeting GSK-3β
Yu, Y., Zhang, Y., Ding, Y.-Q., Bi, X., Yuan, J., Zhou, H., Wang, P., Zhang, L., & Ye, J. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0498-z · Cited by 47
Endogenous IL-10 Contributes to Wound Healing and Regulates Tissue Repair
Short, W. D., Rae, M. M., Lu, T., Padon, B. W., Prajapati, T. J., Faruk, F., Olutoye, O. O., Yu, L., Bollyky, P. L., Keswani, S. G., et al. (2022) · Journal of Surgical Research · doi:10.1016/j.jss.2022.12.004 · Cited by 56
Somanader, D. V. N., Zhao, P., Widdop, R. E., & Samuel, C. S. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116130 · Cited by 54
Gueuvoghlanian‐Silva, B. Y., Bellelis, P., Barbeiro, D. F., Hernandes, C., & Podgaec, S. (2018) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2018.02.003 · Cited by 49
Pathophysiology and Future Therapeutic Perspectives for Resolving Fibrosis in Peyronie’s Disease
Milenkovic, U., Ilg, M. M., Cellek, S., & Albersen, M. (2019) · Sexual Medicine Reviews · doi:10.1016/j.sxmr.2019.02.004 · Cited by 46
Natural Products that Target the NLRP3 Inflammasome to Treat Fibrosis
Ding, N., Wei, B., Fu, X., Wang, C., & Wu, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.591393 · Cited by 54
Dabaghi, M., Saraei, N., Carpio, M. B., Nanduri, V., Ungureanu, J., Babi, M., Chandiramohan, A., Noble, A., Revill, S. D., Zhang, B., et al. (2021) · Cells · doi:10.3390/cells10061538 · Cited by 46
Inflammatory bowel disease–associated intestinal fibrosis
Park, J. M., Kim, J., Lee, Y. J., Bae, S. U., & Lee, H. W. (2023) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2022.11.02 · Cited by 52
Liver Fibrosis Reversion After Suppression of Hepatitis B Virus
Rockey, D. C. (2016) · Clinics in Liver Disease · doi:10.1016/j.cld.2016.06.003 · Cited by 49
Self-citationThe role of cellular senescence in aging through the prism of Koch-like criteria
Yanai, H., & Fraifeld, V. E. (2018) · Ageing Research Reviews · doi:10.1016/j.arr.2017.10.004 · Cited by 45
Fibrosis reversal after hepatitis C virus elimination
Rockey, D. C. (2019) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000524 · Cited by 47
Self-citationThe Emerging Role of Innate Immunity in Chronic Kidney Diseases
Tang, P. C., Zhang, Y.-Y., Chan, M. K., Lam, W. W.-Y., Chung, J. Y., Kang, W., To, K., Lan, H. Y., & Tang, P. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21114018 · Cited by 49
Liu, H., Wu, M., Jia, Y., Niu, L., Huang, G., & Xu, F. (2020) · NPG Asia Materials · doi:10.1038/s41427-020-0226-7 · Cited by 48
Sun, Z., Yang, Z., Wang, M., Huang, C., Ren, Y., Zhang, W., Gao, F., Cao, L., Li, L., & Nie, S. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.08.004 · Cited by 48
Cardiac stem cells: Current knowledge and future prospects
Mehanna, R. A., Essawy, M. M., Barkat, M. A., Awaad, A. K., Thabet, E. H., Hamed, H. A., Elkafrawy, H., Khalil, N. A., Sallam, A., Kholief, M., et al. (2022) · World Journal of Stem Cells · doi:10.4252/wjsc.v14.i1.1 · Cited by 46
Emerging role for branched-chain amino acids metabolism in fibrosis
Wu, T., Wang, M., Ning, F., Zhou, S., Hu, X., Xin, H., Reilly, S. N., & Zhang, X. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106604 · Cited by 48
Delivery of nitric oxide with a pH-responsive nanocarrier for the treatment of renal fibrosis
Lee, T., Lu, H., Cheng, H., Huang, H., Tsai, Y., Chang, I., Tu, C.-P., Chung, C.-W., Lu, T., Peng, C., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.12.059 · Cited by 50
Spermidine from arginine metabolism activates Nrf2 and inhibits kidney fibrosis
Aihara, S., Torisu, K., Uchida, Y., Imazu, N., Nakano, T., & Kitazono, T. (2023) · Communications Biology · doi:10.1038/s42003-023-05057-w · Cited by 52
EP300 as a Molecular Integrator of Fibrotic Transcriptional Programs
Rubio, K., Molina-Herrera, A., Pérez-González, A., Hernández‐Galdámez, H. V., Piña‐Vázquez, C., Araujo-Ramos, T., & Singh, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512302 · Cited by 51
Piatnitskaia, S., Альбертовна, Р. Г., Bilyalov, A. R., Chugunov, S. S., Akhatov, I., Павлов, В. Н., & Kzhyshkowska, J. G. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1349461 · Cited by 47
Ma, G., Samad, I., Motz, K., Yin, L. X., Duvvuri, M., Ding, D., Namba, D. R., Elisseeff, J. H., Horton, M. R., & Hillel, A. T. (2016) · The Laryngoscope · doi:10.1002/lary.26254 · Cited by 46
Indole-Based Small Molecules as Potential Therapeutic Agents for the Treatment of Fibrosis
Qin, R., Zhao, Q., Han, B., Zhu, H.-P., Peng, C. Y., Zhan, G., & Huang, W. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.845892 · Cited by 46
Cardiomyocyte Proliferation from Fetal- to Adult- and from Normal- to Hypertrophy and Failing Hearts
Bishop, S. P., Zhang, J. J., & Ye, L. (2022) · Biology · doi:10.3390/biology11060880 · Cited by 50
Wang, Y., Jia, L., Hu, Z., Entman, M. L., Mitch, W. E., & Wang, Y. (2017) · Kidney International · doi:10.1016/j.kint.2017.04.033 · Cited by 45
Kanlaya, R., & Thongboonkerd, V. (2019) · Current Developments in Nutrition · doi:10.1093/cdn/nzz101 · Cited by 46
Modulation of retinoid signaling: therapeutic opportunities in organ fibrosis and repair
Wang, S., Yu, J., Kane, M. A., & Moise, A. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107415 · Cited by 47
Yu, Y., Leng, Y., Song, X., Mu, J., Ma, L., Yin, L., Zheng, Y., Lü, Y., Li, Y.-N., Qiu, X., et al. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.319119 · Cited by 44
Varshney, R., Murphy, B., Woolington, S., Ghafoory, S., Chen, S., Robison, T., & Ahamed, J. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018025817 · Cited by 45
Dai, C., He, L., Ma, B., & Chen, T. (2019) · Small · doi:10.1002/smll.201902642 · Cited by 57
Hopkins, A. A., Murphy, R., Irnaten, M., Wallace, D., Quill, B., & O'Brien, C. J. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00054.2020 · Cited by 42
Marangoni, R. G., Korman, B. D., & Varga, J. (2020) · Current Rheumatology Reports · doi:10.1007/s11926-020-00957-w · Cited by 42
A new Twist in kidney fibrosis
Ovadya, Y., & Krizhanovsky, V. (2015) · Nature Medicine · doi:10.1038/nm.3938 · Cited by 42
Kattih, B., Boeckling, F., Shumliakivska, M., Tombor, L., Rasper, T., Schmitz, K., Hoffmann, J., Nicin, L., Abplanalp, W. T., Carstens, D. C., et al. (2023) · Cardiovascular Research · doi:10.1093/cvr/cvad140 · Cited by 45
Li, X., Liu, Y., Tang, Y., & Xia, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1474688 · Cited by 67
Bigaeva, E., Gore, E., Simon, E., Zwick, M., Oldenburger, A., de Jong, K. P., Hofker, H. S., Schlepütz, M., Nicklin, P. L., Boersema, M., et al. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02611-6 · Cited by 44
“Point of no return” in unilateral renal ischemia reperfusion injury in mice
Holderied, A., Kraft, F., Marschner, J. A., Weidenbusch, M. J., & Anders, H. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-020-0623-9 · Cited by 45
Eremichev, R. Y., Kulebyakina, M., Alexandrushkina, N. A., Nimiritsky, P., Basalova, N. A., Grigorieva, O., Egiazaryan, M., Dyikanov, D. T., Va, T., & Макаревич, П. И. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.616893 · Cited by 42
Urine Uromodulin as a Biomarker of Kidney Tubulointerstitial Fibrosis
Melchinger, H. C., Calderon-Gutierrez, F., Obeid, W., Xu, L., Shaw, M. M., Luciano, R. L., Kuperman, M. B., Moeckel, G. W., Kashgarian, M. J., Wilson, F. P., et al. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.04360422 · Cited by 43
Zou, Y., Xiong, J.-B., Ma, K., Wang, A., & Qian, K. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.07.074 · Cited by 42
Hepatic Fibrosis and Cirrhosis
Rockey, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch105 · Cited by 41
Self-citationApplication of glucagon-like peptide-1 receptor antagonists in fibrotic diseases
Yang, F., Luo, X., Li, J., Yu, L., Zeng, F., Huang, X., Lan, Y., & Liu, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113236 · Cited by 44
The Role of Extracellular Matrix in Wound Healing
Lin, P., Zhang, G., & Li, H. (2023) · Dermatologic Surgery · doi:10.1097/dss.0000000000003779 · Cited by 48
Jing, H., Ren, Y., Zhou, Y., Xu, M., Křížková, S., Heger, Z., Lü, Q., Wang, S., Liang, X., Adam, V., et al. (2023) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2023.08.020 · Cited by 42
Actomyosin Activity and Piezo1 Activity Synergistically Drive Urinary System Fibroblast Activation
Chen, G., Gao, X., Chen, J., Peng, L., Chen, S., Tang, C., Dai, Y., Wei, Q., & Luo, D. (2023) · Advanced Science · doi:10.1002/advs.202303369 · Cited by 46
Marcos‐Garcés, V., Harvat, M., Aguilar, P. M., Izquierdo, A. F., & Ruiz‐Saurí, A. (2017) · Journal of Microscopy · doi:10.1111/jmi.12553 · Cited by 41
Endothelin-1 is associated with fibrosis in proliferative diabetic retinopathy membranes
Chang, W. K., Lajko, M., & Fawzi, A. A. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191285 · Cited by 40
Adaptive Fibrogenic Reprogramming of Osteosarcoma Stem Cells Promotes Metastatic Growth
Zhang, W., Zhao, J.-M., Lin, J., Hu, C.-Z., Zhang, J., YANG, W.-L., Zhang, J., Zhang, J., & Zhu, J. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.06.103 · Cited by 44
Gwon, M., An, H., Kim, J., Kim, W., Gu, H., Kim, H., Leem, J., Jung, H. J., & Park, K. (2019) · The FASEB Journal · doi:10.1096/fj.201901307rr · Cited by 42
Jing, H., Tang, S., Lin, S., Liao, M., Chen, H., Fan, Y., & Zhou, J. (2020) · Aging · doi:10.18632/aging.102811 · Cited by 42
Ishay, Y., Nachman, D., Khoury, T., & Ilan, Y. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00003.2020 · Cited by 42
Pathology of Fibrosis in Crohn's Disease—Contribution to Understanding Its Pathogenesis
Zidar, N., Langner, C., Jerala, M., Boštjančič, E., Drobne, D., & Tomažič, A. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00167 · Cited by 43
3D Myocardial Mechanical Wave Measurements
Salles, S., Espeland, T., Rodríguez-Molares, A., Aase, S. A., Hammer, T. A., Støylen, A., Aakhus, S., Løvstakken, L., & Torp, H. G. (2020) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2020.05.037 · Cited by 47
Soluble Dipeptidyl Peptidase-4 Induces Fibroblast Activation Through Proteinase-Activated Receptor-2
Lee, S.-Y., Wu, S.-T., Liang, Y., Su, M., Huang, C.-W., Jao, Y.-H., & Ku, H.-C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.552818 · Cited by 42
Emerging role of CCN family proteins in fibrosis
Sun, C., Zhang, H., & Liu, X. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.30171 · Cited by 47
Zhang, B., Tan, Y., Zhang, Z., Feng, P., Ding, W., Wang, Q., Liang, H., Duan, W., Wang, X., Yu, S., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/9187065 · Cited by 44
Liver Fibrosis—From Mechanisms of Injury to Modulation of Disease
Liedtke, C., Nevzorova, Y. A., Luedde, T., Zimmermann, H., Kroy, D., Strnad, P., Berres, M.-L., Bernhagen, J., Tacke, F., Nattermann, J., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2021.814496 · Cited by 37
Mimche, P. N., Lee, C. M., Mimche, S. M., Thapa, M., Grakoui, A., Henkemeyer, M. J., & Lamb, T. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-20926-9 · Cited by 44
Hseu, Y., Yang, T., Li, M., Rajendran, P., Mathew, D. C., Tsai, C.-H., Lin, R., Lee, C.-C., & Yang, H. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13973 · Cited by 43
Metadata
- Authors
- Rockey, D. C., Bell, P. D., & Hill, J. A.
- Affiliations
- Medical University of South Carolina (US)
- The University of Texas Southwestern Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2015-03-19
- Volume
- 372
- Issue
- 12
- Pages
- 1138-1149
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1977437151
- Cited by
- 1,428
- References
- 118
- Citations by year
- 2026: 104 · 2025: 116 · 2024: 154 · 2023: 149 · 2022: 162 · 2021: 162 · 2020: 152 · 2019: 118 · 2018: 96 · 2017: 94 · 2016: 85 · 2015: 33
- FWCI
- 14.71
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Keywords
- fibrosis, organ damage, organ failure, inflammation, fibrosis mechanisms, fibrosis treatment
- MeSH terms
- Fibrosis, Humans, Multiple Organ Failure, Transforming Growth Factor beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.